Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00
Provider: Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Boston Scientific Corp Receives CE Mark For Lotus Valve System


Monday, 28 Oct 2013 09:09am EDT 

Boston Scientific Corp announced that it has received CE Mark for the Lotus Valve System, the Company's advanced transcatheter aortic valve replacement (TAVR) technology. This key approval offers effective new treatment alternative for patients with severe aortic stenosis at high risk with surgical valve replacement. 

Company Quote

13.29
0.19 +1.45%
11 Jul 2014